Search clinical trials for: SHR6390(125mg)

Total 668 results

Drug Induced Liver Disease Study Group
Beijing Union Pharmaceutical Factory

Completed

The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI

Drug-Induced Acute Liver Injury

China
Andrew Carr

Completed

Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men. (EPEP)

HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men

Australia
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

Hypercholesterolemia

Japan
Nanjing First Hospital, Nanjing Medical University

Recruiting

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Assistance Publique - Hôpitaux de Paris

Completed

Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth (BETADOSE)

Neonatal Complications

France
HanAll BioPharma Co., Ltd.

Completed

Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

Hypertension

Korea, Republic of
Penang Hospital, Malaysia

Completed

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

End Stage Renal Failure

Malaysia
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Drug-drug Interaction,SHR3680

China
CytoDyn, Inc.
Amarex Clinical Research

Withdrawn

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Colorectal Cancer | Microsatellite Stable | Metastatic | CCR5
Canadian Cancer Trials Group
Pfizer

Completed

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

Breast Cancer

Canada
Federal State Budget Institution Research Center...

Active, not recruiting

Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency

Primary Ovarian Insufficiency

Russian Federation
SanQing Jin

Completed

Observation of Propofol Titration at Different Speeds (OPTDS)

Anesthesia, General | Hemodynamics

China
Daiichi Sankyo Co., Ltd.

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

Non-valvular Atrial Fibrillation

Japan
Hospital Infantil Albert Sabin

Completed

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

Pain, Postoperative | Vomiting | Anesthesia | Agitation States as Acute Reaction to Exceptional Stress

Brazil
University of Magdeburg
Bayer

Completed

Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin (SKADI)

Acne Vulgaris

Germany
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Prostate Cancer Patients

China
Charite University, Berlin, Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Unknown

Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)

Moderate to Severe Active Axial Spondyloarthritis

Germany
Hematology Oncology Associates of Central New York

Not yet recruiting

PFA 100 Evaluation and Reference Interval HOACNY

Effect of Drug
Daewon Pharmaceutical Co., Ltd.
Asan Medical Center

Completed

Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition

Healthy

Korea, Republic of
PharmaKing

Completed

Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis

Non-alcholic Fatty Liver Disease

Korea, Republic of
Fundacion SEIMC-GESIDA

Active, not recruiting

Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities (MIND)

HIV Infections

Spain
The University of Texas Health Science Center at...
Baptist Health Foundation of San Antonio

Recruiting

Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM)

Cardiovascular Diseases | Weight, Body | Pre-Diabetes

United States
Far Eastern Memorial Hospital

Recruiting

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
Shen Lin
307 Hospital of PLA; Tianjin Medical University Cancer Institute and Hospital; Beijing Union Hosptial and other collaborators

Completed

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China (SCI-101)

Colorectal Cancer

China
Boehringer Ingelheim

Completed

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

Cerebrovascular Accident

Germany
Yuhan Corporation

Completed

Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac

Healthy

Korea, Republic of
Sichuan Cancer Hospital and Research Institute
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC

Lung Cancer Metastatic

China
Qianfoshan Hospital

Not yet recruiting

Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer

Oxycodone
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense; Sharp Clinical Services, Inc

Recruiting

Using Aspirin to Improve Immunological Features of Ovarian Tumors

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
Gangnam Severance Hospital

Completed

Orlistat/Phentermine Versus Placebo/Phentermine

Obesity | Overweight

Korea, Republic of
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Effects of Dronabinol (Oral THC) on Cannabis Use

Marijuana Smoking

United States
Royal Marsden NHS Foundation Trust
Pfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaborators

Recruiting

A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer (TRAK-ER)

HER2-negative Breast Cancer | ER+ Breast Cancer

United Kingdom, France
NYU Langone Health

Recruiting

Body Weight, Aspirin Dose and Pro-resolving Mediators

Body Weight

United States
Aswan University

Completed

Comparative Study Among Different Doses of Ephedrine During Elective Cesarean Section Under Subarachnoid Block.

Cesarean Section Complications | Anesthesia | Subarachnoid Block

Egypt
Pfizer

Completed

A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers

Biological Availability

United States
AstraZeneca

Completed

Study of Verinurad in Heart Failure With Preserved Ejection Fraction (AMETHYST)

Heart Failure With Preserved Ejection Fraction (HFpEF)

United States, Germany, Canada, Korea, Republic of, Austria, Slovakia, Australia, Bulgaria, Russian Federation, Argentina, Poland, Mexico
Assiut University

Completed

Ultrasound Guided TAP Block for Postoperative Analgesia After Abdominal Surgery. (TAB)

Postoperative Pain

Egypt
LG Life Sciences

Completed

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Henan Cancer Hospital

Not yet recruiting

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

Advanced Breast Cancer | Treatment | HR Low/HER2 Negative
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder

Overactive Bladder

Bangladesh
GlaxoSmithKline

Completed

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Diabetes Mellitus, Type 2

Spain, United Kingdom, United States, France
Daiichi Sankyo Co., Ltd.

Completed

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Embolism and Thrombosis | Thrombosis | Deep Vein Thrombosis | Thromboembolism | Venous Thromboembolism | Arthroplasty, Replacement, Hip

Japan, Taiwan
Lori Gawron
Planned Parenthood Association of Utah

Recruiting

Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo

Emergency Contraception

United States
University of Utah

Completed

Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma

Melanoma (Skin)

United States
Boehringer Ingelheim

Completed

SMOOTH - Blood Pressure Control in Diabetic/Obese Patients

Hypertension | Diabetes Mellitus, Type 2

Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Trial to Determine Effective Aspirin Dose in COPD

Pulmonary Disease, Chronic Obstructive

United States
University of Utah

Completed

Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma

Melanoma (Skin)

United States
Mereo BioPharma

Completed

The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

Interaction

United States
Children's Hospital of Michigan

Completed

Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children

Moderate, Deep Sedation
Loma Linda University

Recruiting

Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA). (BASA)

Blunt Cerebrovascular Injury

United States

Search clinical trials for: SHR6390(125mg)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations